It could take five to 10 years before the health industry fully understands “if, where and how” cannabis fits into the range of medicines used to treat patients, delegates at the Princess Alexandra Hospital Online Health Symposium have been told.
Queensland Health manager Tanya Bain said in the meantime, regulators and healthcare practitioners will continue to juggle the “fine line between patient expectation and evidence-based medicine”.
She added while the industry is still in its infancy, increasing doctor acceptance and a growing patient base are contributing to SAS-B approvals averaging around 9,000 since the start of the year.
Bain suggested the anticipated introduction of Queensland’s Medicines and Poisons Act 2019 this year will boost numbers still further.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
